Rupnik, M, Wilcox, MH, Gerding, DN.
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Reviews Microbiology
2009; 7: 526–536.
Kuijper, EJ, Coignard, B, Tull, P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection
2006; 12 (Suppl. 6): 2–18.
Alvarez, M, et al.
Diagnosis of Clostridium difficile diarrhoea: in search of a more efficient clinical focus [in Spanish]. Revista Medica de Chile
2001; 129: 620–625.
Herrera, P, et al.
High incidence and complications of Clostridium difficile diarrhoea among patients with renal diseases [in Spanish]. Revista Medica de Chile
2003; 131: 397–403.
Hernandez-Rocha, C, et al.
Epidemic Clostridium difficile ribotype 027 in Chile. Emerging Infectious Diseases
2012; 18: 1370–1372.
Sociedad Chilena de, I. Report: Clostridium difficile outbreak at the Dr. Alejandro del Rio emergency hospital in Santiago, Chile [in Spanish]. Revista Chilena de Infectologia
2012; 29: 531–538.
Hernandez-Rocha, C, et al.
Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections. Diagnostic Microbiology and Infectious Disease
2013; 75: 361–365.
Evans, CT, Safdar, N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clinical Infectious Diseases
2015; 60 (Suppl. 2): S66–71.
Bauer, MP, et al.
Clostridium difficile infection in Europe: a hospital-based survey. Lancet
2011; 377: 63–73.
Bidet, P, et al.
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Letters
1999; 175: 261–266.
Clostridium difficile toxinotyping. Methods in Molecular Biology
2010; 646: 67–76.
Oka, K, et al.
Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. Journal of Clinical Microbiology
2012; 50: 915–921.
Cohen, SH, et al.
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection Control and Hospital Epidemiology
2010; 31: 431–455.
Quesada-Gomez, C, et al.
Emergence of an outbreak-associated Clostridium difficile variant with increased virulence. Journal of Clinical Microbiology
2015; 53: 1216–1226.
Argamany, JR, et al.
Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001–2010. American Journal of Infection Control
2015; 43: 435–440.
Freeman, J, et al.
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clinical Microbiology and Infection
2015; 21: 248.e9–248.e16.
Noren, T, Johansson, K, Unemo, M.
Clostridium difficile PCR ribotype 046 is common among neonatal pigs and humans in Sweden. Clinical Microbiology and Infection
2014; 20: O2–6.
Pituch, H, et al.
Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. Journal of Medical Microbiology
2006; 55: 207–213.
Aguayo, C, et al.
Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiology and Infection
2015; 143: 3069–3073.